Literature DB >> 28884213

Reply to Radbruch et al.: 'interpreting signal-intensity ratios without visible T1 hyperintensities in clinical gadolinium retention studies'.

Maria Camilla Rossi Espagnet1, Paolo Tomà2, Antonio Napolitano3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28884213     DOI： 10.1007/s00247-017-3971-1

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN： 0301-0449


× No keyword cloud information.
  13 in total

1.  Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.

Authors:  Alexander Radbruch; Lukas D Weberling; Pascal J Kieslich; Oliver Eidel; Sina Burth; Philipp Kickingereder; Sabine Heiland; Wolfgang Wick; Heinz-Peter Schlemmer; Martin Bendszus
Journal:  Radiology       Date:  2015-04-06       Impact factor: 11.105

2.  Distribution map of gadolinium deposition within the cerebellum following GBCA administration.

Authors:  Donna R Roberts; Cynthia A Welsh; David P LeBel; W Clay Davis
Journal:  Neurology       Date:  2017-02-15       Impact factor: 9.910

3.  High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.

Authors:  Tomonori Kanda; Marie Osawa; Hiroshi Oba; Keiko Toyoda; Jun'ichi Kotoku; Takahiro Haruyama; Koji Takeshita; Shigeru Furui
Journal:  Radiology       Date:  2015-01-27       Impact factor: 11.105

4.  Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation.

Authors:  Yuri Errante; Vincenzo Cirimele; Carlo Augusto Mallio; Vincenzo Di Lazzaro; Bruno Beomonte Zobel; Carlo Cosimo Quattrocchi
Journal:  Invest Radiol       Date:  2014-10       Impact factor: 6.016

5.  Gadodiamide and Dentate Nucleus T1 Hyperintensity in Patients With Meningioma Evaluated by Multiple Follow-Up Contrast-Enhanced Magnetic Resonance Examinations With No Systemic Interval Therapy.

Authors:  Carlo Cosimo Quattrocchi; Carlo Augusto Mallio; Yuri Errante; Vincenzo Cirimele; Luciano Carideo; Antonella Ax; Bruno Beomonte Zobel
Journal:  Invest Radiol       Date:  2015-07       Impact factor: 6.016

6.  Pediatric Brain: No Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-weighted MR Images after Consecutive Exposure to a Macrocyclic Gadolinium-based Contrast Agent.

Authors:  Alexander Radbruch; Robert Haase; Philipp Kickingereder; Philipp Bäumer; Sebastian Bickelhaupt; Daniel Paech; Wolfgang Wick; Heinz-Peter Schlemmer; Angelika Seitz; Martin Bendszus
Journal:  Radiology       Date:  2017-03-08       Impact factor: 11.105

7.  Signal intensity at unenhanced T1-weighted magnetic resonance in the globus pallidus and dentate nucleus after serial administrations of a macrocyclic gadolinium-based contrast agent in children.

Authors:  Maria Camilla Rossi Espagnet; Bruno Bernardi; Luca Pasquini; Lorenzo Figà-Talamanca; Paolo Tomà; Antonio Napolitano
Journal:  Pediatr Radiol       Date:  2017-05-19

8.  High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.

Authors:  Joana Ramalho; Mauricio Castillo; Mamdoh AlObaidy; Renato H Nunes; Miguel Ramalho; Brian M Dale; Richard C Semelka
Journal:  Radiology       Date:  2015-06-16       Impact factor: 11.105

9.  Pediatric Brain: Repeated Exposure to Linear Gadolinium-based Contrast Material Is Associated with Increased Signal Intensity at Unenhanced T1-weighted MR Imaging.

Authors:  Thomas F Flood; Nicholas V Stence; John A Maloney; David M Mirsky
Journal:  Radiology       Date:  2016-07-28       Impact factor: 11.105

10.  Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent.

Authors:  D R Roberts; A R Chatterjee; M Yazdani; B Marebwa; T Brown; H Collins; G Bolles; J M Jenrette; P J Nietert; X Zhu
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-28       Impact factor: 3.825
View more
  4 in total

1.  Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.

Authors:  Alessandra Splendiani; Marco Perri; Claudia Marsecano; Valentina Vellucci; Giulia Michelini; Antonio Barile; Ernesto Di Cesare
Journal:  Radiol Med       Date:  2017-09-27       Impact factor: 3.469

Review 2.  Gadolinium-based contrast agents - review of recent literature on magnetic resonance imaging signal intensity changes and tissue deposits, with emphasis on pediatric patients.

Authors:  Einat Blumfield; David W Swenson; Ramesh S Iyer; A Luana Stanescu
Journal:  Pediatr Radiol       Date:  2019-03-29

Review 3.  A Review of the Current Evidence on Gadolinium Deposition in the Brain.

Authors:  Richard Pullicino; Mark Radon; Shubhabrata Biswas; Maneesh Bhojak; Kumar Das
Journal:  Clin Neuroradiol       Date:  2018-03-09       Impact factor: 3.649

Review 4.  How the Chemical Properties of GBCAs Influence Their Safety Profiles In Vivo.

Authors:  Quyen N Do; Robert E Lenkinski; Gyula Tircso; Zoltan Kovacs
Journal:  Molecules       Date:  2021-12-23       Impact factor: 4.927
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.